
KURA Valuation
Kura Oncology Inc
- Overview
- Forecast
- Valuation
- Earnings
KURA Relative Valuation
KURA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KURA is overvalued; if below, it's undervalued.
Historical Valuation
Kura Oncology Inc (KURA) is now in the Fair zone, suggesting that its current forward PS ratio of 2.50 is considered Fairly compared with the five-year average of -7.76. The fair price of Kura Oncology Inc (KURA) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:6.23
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.43
P/B
Median3y
2.25
Median5y
2.59
19.83
FCF Yield
Median3y
-8.26
Median5y
-7.83
Competitors Valuation Multiple
The average P/S ratio for KURA's competitors is 34.39, providing a benchmark for relative valuation. Kura Oncology Inc Corp (KURA) exhibits a P/S ratio of 2.50, which is -92.74% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

RXT
Rackspace Technology Inc
1.325
USD
-1.85%

FPI
Farmland Partners Inc
10.590
USD
-6.37%

MPB
Mid Penn Bancorp Inc
27.020
USD
+1.20%

VREX
Varex Imaging Corp
7.850
USD
+3.97%

ACCD
Accolade Inc
0
USD
-0.14%

TEN
Tsakos Energy Navigation Ltd
19.400
USD
-1.97%

CHCT
Community Healthcare Trust Inc
16.560
USD
+0.98%

PRCH
Porch Group Inc
13.420
USD
+1.21%

SCHL
Scholastic Corp
26.700
USD
+23.90%

PGC
Peapack-Gladstone Financial Corp
26.400
USD
+2.01%
FAQ

Is Kura Oncology Inc (KURA) currently overvalued or undervalued?
Kura Oncology Inc (KURA) is now in the Fair zone, suggesting that its current forward PS ratio of 2.50 is considered Fairly compared with the five-year average of -7.76. The fair price of Kura Oncology Inc (KURA) is between to according to relative valuation methord.

What is Kura Oncology Inc (KURA) fair value?

How does KURA's valuation metrics compare to the industry average?

What is the current P/B ratio for Kura Oncology Inc (KURA) as of Jul 26 2025?

What is the current FCF Yield for Kura Oncology Inc (KURA) as of Jul 26 2025?

What is the current Forward P/E ratio for Kura Oncology Inc (KURA) as of Jul 26 2025?
